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and Jayakrishna Ambati1,4
1Department of Ophthalmology and Visual Sciences
2Department of Biomedical Engineering
3Department of Microbiology, Immunology, and Human Genetics
4Department of Physiology
University of Kentucky, Lexington, KY 40536, USA
5Proteomics Laboratory, Mass Spectrometry Research Center and Department of Biochemistry, Vanderbilt University School of Medicine,
Nashville, TN 37205, USA
6Department of Pathology and Comprehensive Cancer Center, University of Michigan Medical School, Ann Arbor, MI 48109, USA
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SUMMARY
Excess iron induces tissue damage and is implicated
in age-related macular degeneration (AMD). Iron
toxicity is widely attributed to hydroxyl radical forma-
tion through Fenton’s reaction. We report that
excess iron, but not other Fenton catalytic metals, in-
duces activation of the NLRP3 inflammasome, a
pathway also implicated in AMD. Additionally, iron-
induced degeneration of the retinal pigmented
epithelium (RPE) is suppressed in mice lacking in-
flammasome components caspase-1/11 or Nlrp3 or
by inhibition of caspase-1. Iron overload increases
abundance of RNAs transcribed from short inter-
spersed nuclear elements (SINEs): Alu RNAs and
the rodent equivalent B1 and B2 RNAs, which are in-
flammasome agonists. Targeting Alu or B2 RNA pre-
vents iron-induced inflammasome activation and
RPE degeneration. Iron-induced SINE RNA accumu-
lation is due to suppression of DICER1 via sequestra-
tion of the co-factor poly(C)-binding protein 2
(PCBP2). These findings reveal an unexpected
mechanism of iron toxicity, with implications for
AMD and neurodegenerative diseases associated
with excess iron.
INTRODUCTION
Iron is a critical component of dozens of enzymatic processes
and, in excess, can induce oxidative damage via Fenton’s reac-
tion, in which iron catalyzes the formation of highly reactive hy-
droxyl radicals. Accordingly, iron overload is implicated in the
pathogenesis of numerous diseases including neurodegenera-
tive disorders such as Alzheimer’s disease, Parkinson’s disease,
and amyotrophic lateral sclerosis (Urrutia et al., 2014). Retinal
iron overload is also implicated in the pathogenesis of age-
related macular degeneration (AMD). For example, human
eyes with AMD display increased iron deposition in the retina
and aqueous humor (Flinn et al., 2014; Hahn et al., 2003; Jüne-
mann et al., 2013) and animal models of iron overload reproduce
AMD-like phenotypes of the retinal pigmented epithelium (RPE)
and outer retina (Flinn et al., 2014; Gnana-Prakasam et al.,
2012; Hadziahmetovic et al., 2008; Hahn et al., 2004). Although
the damaging effects of iron overload are often attributed to
oxidative damage, the precise mechanisms driving iron-induced
retinal toxicity have not been defined.
Here, we report a mechanism of iron-induced retinal degener-
ation unique among several Fenton-capable metals that requires
the specific activation of the NLRP3 inflammasome, an innate
immune signaling complex recently implicated in AMD patho-
genesis. We also report that iron induces NLRP3 inflammasome
signaling via induction of Alu RNAs derived from short inter-
spersed nuclear elements (SINEs), which are endogenous in-
flammasome activators abundant in humanAMD. These findings
suggest that the intrinsic toxicity of excess iron in the retina de-
pends upon the activation of SINE RNA-mediated innate im-
mune signaling.
RESULTS
Iron Overload Activates the NLRP3 Inflammasome
Given the apparent role of iron overload in retinal degeneration,
we sought to determine the effect of iron on the RPE cell layer,
which provides essential support to photoreceptors and the
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degeneration of which demarcates atrophic AMD. The NLRP3
inflammasome is an immune signaling complex implicated in
the pathogenesis of AMD (Anderson et al., 2013; Kauppinen
et al., 2012; Liu et al., 2013; Marneros, 2013; Tarallo et al.,
2012; Tseng et al., 2013). In models of atrophic AMD, NLRP3 in-
flammasome activation induces cellular death via the inflamma-
some effector caspase-1 (Tarallo et al., 2012). Therefore, we
sought to determine whether iron overload activated the
NLRP3 inflammasome. We examined mice doubly deficient in
genes encoding the cellular iron exporters ceruloplasmin and he-
phaestin (Cp/Heph/) that exhibit age-dependent retinal iron
deposition and AMD-like pathologies (Hadziahmetovic et al.,
2008; Hahn et al., 2004). Similar to previous reports of human
geographic atrophy tissues (Tarallo et al., 2012; Tseng et al.,
2013), we detected robust expression of the inflammasome-
related gene Nlrp3 in the RPE layer of Cp/Heph/ mice
compared to age-matched wild-type controls (Figure 1A). We
sought to determine whether acute administration of Fe(III)
induced RPE degeneration and inflammasome activation. Seven
days after subretinal injection of Fe(III), we detected degenera-
tion of the RPE (Figure 1B) reminiscent of both human atrophic
AMD and mouse models of NLRP3 inflammasome-induced
RPE degeneration (Fowler et al., 2014; Kaneko et al., 2011; Tar-
allo et al., 2012). Both subretinal delivery of iron in wild-typemice
and iron loading of human RPE cells induced caspase-1 matura-
tion (Figures 1C and 1D). To further investigate the anatomic
location of inflammasome activation, we assessed in situ cas-
pase-1 activity in unfixed retinal cryo-sections by administering
a caspase-1 peptide substrate that becomes fluorescent upon
cleavage. We observed elevated caspase-1 proteolytic activity
in the RPE cell layer of wild-typemice following iron subretinal in-
jection (Figure S1A). We confirmed the signal was not due to
accumulation of auto-fluorescent material in iron-treated wild-
type mice without substrate and in iron-treated caspase-1/11
knockout mice (Figure S1B). Together, these results implicate
iron overload as an inflammasome agonist in the RPE. We next
sought to determine whether iron-induced inflammasome acti-
vation was due to Fenton catalytic activity. Other multivalent
metal ions such as Cr(VI), Cu(I), and Zn(I) are also efficient Fenton
catalysts. Loading RPE cells with metal ions induced free radical
formation (Figure S1C). However, unlike Fe(III), loading human
RPE cells with Cr(VI), Cu(I), or Zn(I) did not induce caspase-1
maturation (Figure S1D). These findings indicate that overload
of Fenton catalytic metals alone is not sufficient to drive inflam-
masome activation.
Inflammasome Is Required for Iron Overload Toxicity
We next sought to determine whether inflammasome signaling
contributed to iron-induced RPE degeneration. Mice lacking
the inflammasome components caspase-1/11 or Nlrp3 were
protected from RPE degeneration upon administration of iron
compared to wild-type mice (Figures 1E and 1F). Interestingly,
Nlrp3 ablation reduced RPE degeneration due to a high dose
of iron injection, albeit less effectively than caspase-1/11 defi-
ciency, implying that in response to large doses of iron, compen-
satory Nlrp3-independent pathways that also require caspase-
1/11 contribute to RPE degeneration. Additionally, blockade of
caspase-1 activity via delivery of a cell-permeable peptide inhib-
itor prevented RPE degeneration due to Fe(III) administration
in wild-type mice (Figure 1G). Together, these data implicate
the NLRP3 inflammasome in mediating iron-induced retinal
toxicity.
We next tested whether other metal ions capable of partici-
pating in Fenton’s reaction induced retinal toxicity. Aswith Fe(III),
each of Cr(VI), Cu(I), and Zn(I) were toxic to the RPE cell layer
(Figure 1H). However, unlike Fe(III), the toxicity of Cr(VI), Cu(I),
and Zn(I) overload persisted in caspase-1/11-deficient mice (Fig-
ure 1I), suggesting that iron toxicity in this system is uniquely in-
flammasome dependent.
Iron Overload Causes Accumulation of Alu, B1, and B2
SINE RNAs
RNAs transcribed from ubiquitous Alu repetitive elements are in-
flammasome activators implicated in atrophic AMD (Dridi et al.,
2012; Kaneko et al., 2011; Tarallo et al., 2012). We sought to
determine whether iron overload induced Alu RNA accumula-
tion. Iron overload induced elevated Alu RNA levels in human
RPE cells (Figure 2A). Rodents also carry SINE repeats such as
B1 and B2 elements that, like Alu repeats, are derived from
non-LTR, non-autonomous retrotransposons (Jurka et al.,
2005). B1 and B2 RNAs can also induce inflammasome signaling
and retinal degeneration (Kaneko et al., 2011; Tarallo et al.,
2012). Subretinal delivery of iron induced a dose-dependent in-
crease in B1 and B2 RNA levels in the RPE/choroid of wild-
type mice but left Dicer1 mRNA levels unchanged (Figure 2B).
Fluorescent in situ hybridization of B1 and B2 RNAs in retina of
6-month-old Cp/Heph/ mice revealed robust enrichment
of these RNAs in multiple retinal layers including the RPE,
choroid, and neural retina of double knockout mice compared
to age-matched wild-type controls (Figure 2C).
We hypothesized that iron toxicity could be due to its ability to
induce Alu RNAs. Administration of an Alu RNA-targeted anti-
sense oligonucleotide in iron-treated human RPE cells abolished
caspase-1 maturation (Figure 2D), implicating Alu RNA as an
intermediate in this process. We previously developed an
antisense oligonucleotide targeted against B2 RNA that is chem-
ically modified for in vivo cell entry and that prevents RPE degen-
eration due to SINE RNA accumulation in mice (Kaneko et al.,
2011; Tarallo et al., 2012). Antagonizing B2 RNA in wild-type
mice prevented iron-induced RPE degeneration in four of six
eyes treated with B2 antisense (compared to zero of six
eyes treated with a scrambled antisense; Fisher’s exact test;
p < 0.03; Figure 2E). Collectively, these data support the concept
that iron overload induces Alu RNA accretion and resulting in-
flammasome-mediated retinal toxicity.
Iron Overload Enhances DICER1-Dependent Alu RNA
Stability
Alu RNA levels are controlled in part by the RNase DICER1 (Hu
et al., 2012; Kaneko et al., 2011; Ren et al., 2012, 2013; Tarallo
et al., 2012; Yan et al., 2013). We previously reported that
DICER1-mediatedAluRNA clearance is essential formaintaining
retinal health (Kerur et al., 2013; Tarallo et al., 2012). We
confirmed that, as with AluRNAs, both B1 and B2 RNAs are sub-
strates for DICER1 enzymatic cleavage (Figure S2). Because free
iron generates reactive oxygen species and the abundance of
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DICER1 is reduced by oxidative stress (Kaneko et al., 2011; Mori
et al., 2012; Wiesen and Tomasi, 2009), we predicted that iron-
induced Alu RNA accumulation was due to transcriptional
repression of DICER1 levels. Surprisingly, iron overload did not
affect DICER1 levels in RPE cells or in wild-type mice (Figures
2A and 2B). Dicer1 mRNA was also unchanged in the RPE of
6-month-old Cp/Heph/ compared to age-matched wild-
type mice (Kaneko et al., 2011), suggesting that induction of
Figure 1. Iron Toxicity Depends on the NLRP3 Inflammasome
(A) Immuno-labeling of Nlrp3 (yellow signal) and nuclei (DAPI, blue signal) in the RPE/choroid of 6-month-old wild-type (top) or Cp/Heph/ mice (middle).
Bottom row depicts the same area from a serial section of Cp/Heph/ immunolabeled with isotype goat IgG. Representative of n = 3 mice. The scale bar
denotes 20 mm.
(B) Fundus (top) and ZO-1 staining of RPE flat mount preparations (bottom) of wild-type mice 7 days after injection of 1 ml Fe(III) at indicated concentrations. Blue
arrows denote injection site.
(C and D) Western blotting of pro- and active forms of caspase-1 in ARPE-19 cells and wild-type mouse retina and RPE/choroid (pooled from four eyes) treated
with indicated doses of Fe(III).
(E and F) Fundus and ZO-1 staining of RPE flat-mount preparations following delivery of Fe(III) into the subretinal space of mice lacking inflammasome com-
ponents caspase-1/11 (E) and Nlrp3 (F).
(G) Fundus and ZO-1 staining of RPE flat-mount preparations of wild-type mice that received caspase-1 peptide inhibitor preceding delivery of Fe(III) into the
subretinal space.
(H and I) Fundus and ZO-1 staining of RPE flat-mount preparations following administration of Cr(VI), Cu(I), or Zn(I) into the subretinal space of wild-type mice (H)
and inmice lacking inflammasome components caspase-1/11 (I). Indicated doses represent theminimum concentration of metals required to consistently induce
RPE degeneration.
(B–I) The scale bars denote 50 mm. Fundus images are representative of at least four replicates.
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Alu or B1 and B2 RNAs by iron overload was not due to suppres-
sion of DICER1 abundance.
We next sought to determinewhether iron affected the stability
of Alu RNA transcripts. Iron overload delayed RPE cell process-
ing of a transfected biotin-labeled Alu RNA (Figure 3A). Further,
whereas excess iron did not affect the transcription rate of
endogenous Alu RNAs, degradation of native Alu RNAs was de-
layed as assessed by a run-on assay (Figure 3B). To determine
whether iron-overload-induced Alu RNA accumulation involved
DICER1 enzymatic activity, we examined this activity in cells
Figure 2. Iron Toxicity Depends on SINE
RNA Induction
(A) Densitometry of Alu RNA northern blotting and
real-time qPCR ofDICER1mRNA in human ARPE-
19 cells exposed to iron overload for 4 days at
indicated doses.
(B) Densitometry of B1 and B2 RNAs northern
blotting and real-time qPCR of Dicer1mRNA RPE/
choroid lysates from wild-type C57BL6/J mice
7 days after subretinal injection with iron.
(C) Fluorescent in situ hybridization of B1 and B2
RNAs in retinal cross-sections of 6-month-old
Cp/Heph/ (top row) or wild-type mice (bottom
row). The scale bar denotes 50 mm.
(D) Western blotting of pro- and active forms of
caspase-1 in ARPE-19 cells exposed to Fe(III) after
treatment with either scrambled or Alu RNA-tar-
geted antisense oligonucleotides.
(E) Representative fundus photographs and ZO-1-
immunostained RPE flat mounts of wild-type mice
treated with a cell-permeable antisense oligonu-
cleotide targeting B2 RNA (and scrambled control)
1 day prior to subretinal injection of 10 nM Fe(III).
Images were acquired 6 days after Fe(III) admin-
istration. Blue arrows denote injection site. The
scale bar denotes 50 mm.
For all panels, n = 3–6; *p < 0.05. Error bars
denote SEM.
treated with an antisense oligonucleotide
targeting DICER1 that itself induces Alu
RNA accumulation (Kaneko et al., 2011;
Tarallo et al., 2012). In DICER1 anti-
sense-treated cells, iron overload did
not further enhance Alu RNA levels (Fig-
ure 3C), suggesting iron may work by
suppressing DICER1 enzymatic activity.
Conversely, iron did not affect recombi-
nant human DICER1-mediated Alu RNA
processing in vitro (Figure 3D), impli-
cating an indirect, iron-sensitive mediator
of DICER1 activity.
PCBP2 Binds to and Enhances
DICER1 Processing of Alu RNA
We investigated potential iron-sensitive
Alu RNA-binding partners by performing
2D liquid chromatography tandem mass
spectrometry on proteins from primary
human RPE cell lysates captured by
pull-down of synthetic biotin-labeled Alu RNA. We identified
poly(C)-binding protein 2 (PCBP2) (Figure S3A), an RNA-binding
protein reported to be both iron sensitive and capable of
modulating DICER1 enzymatic activity for micro-RNA process-
ing (Li et al., 2012). It is reported that free cellular iron impairs
DICER1 microRNA processing by decreasing its affinity for
PCBP2 (Li et al., 2012). Because, like microRNAs, Alu RNAs
are enzymatic targets of DICER1, we investigated whether a
similar mechanism was responsible for iron-induced Alu RNA
accumulation. We confirmed the interaction of PCBP2 and Alu
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RNA by streptavidin-mediated pull-down of a biotin-labeled Alu
RNA followed by immunoblotting for PCBP2 (Figure 4A) and
conversely via antibody-mediated pull-down of endogenous
PCBP2 followed by northern blotting for native Alu RNA (Fig-
ure 4B). Whereas iron treatment neither impaired Alu RNA-
DICER1 binding nor decreased PCBP2 expression, PCBP2-Alu
RNA binding was decreased by iron overload (Figures 4A and
4B). The affinity of DICER1 for Alu RNA was unchanged by iron
overload (Figure 4A), as is the case for DICER1 pre-microRNA
processing activity inhibition by iron (Li et al., 2012). Alu RNA/
PCBP2 binding specificity was further confirmed by performing
a competition assay with 5-fold excess of unlabeled in vitro tran-
scribed human pre-Let-7a microRNA, which binds to PCBP2
and DICER1 (Li et al., 2012) or unlabeled tRNA (with no known
binding affinity for PCBP2; Figure S3B). To examine the effect
of PCBP2 on DICER1-mediated processing of Alu RNAs, we
measured the efficiency of Alu RNA processing by DICER1
in vitro in the presence of recombinant human PCBP2 and
iron. Whereas iron or PCBP2 alone did not affect DICER1-medi-
ated Alu RNA processing, recombinant PCBP2 enhanced
DICER1-mediated Alu RNA cleavage, which was significantly
impaired in the presence of iron (Figure 4C). Collectively, these
data identify PCBP2 as an iron-sensitive co-factor for DICER1-
mediated Alu RNA enzymatic processing.
DISCUSSION
Our data establish an alternative paradigm for iron-overload-
induced retinal toxicity—namely that iron overload enhances
Alu RNA stability and thereby promotes RPE degeneration via
the NLRP3 inflammasome (Figure 4D). Iron toxicity in the retina
and other tissues is widely attributed to catalysis of hydroxyl rad-
icals via Fenton’s reaction. However, our findings reveal that,
absent SINE RNA accumulation or caspase-1 signaling, iron
overload is not sufficient to drive degeneration of the retina.
We further report that iron-overload-induced AluRNA/inflamma-
some-mediated retinal toxicity is not a generic response to
excess of Fenton catalysts, as this pathway was not common
to chromium-, copper-, or zinc-induced retinal toxicity.
Although our data suggest that hydroxyl radical formation is
not sufficient to drive inflammasome-mediated retinal toxicity,
the necessity of iron-mediated hydroxyl radical formation on
Alu RNA-mediated iron toxicity is not known. We previously re-
ported that Alu RNAs induce mitochondrial reactive oxygen
species generation, which is an essential component of its in-
flammasome signaling and toxicity (Tarallo et al., 2012). That
Alu RNA signaling involves reactive oxygen species generation
and iron’s ability to catalyze free radical formation suggests
that Fenton activity of iron could augment Alu RNA toxicity.
Iron antagonism of DICER1 in the RPE likely impacts not only
AluRNAmetabolism but microRNA biogenesis as well. Although
we previously found no anatomical disruption of microRNA-defi-
cient RPE of adult mice (RPE-specific knockouts of Drosha,
Dgcr8, and argonaute-2 appeared normal upon fundus and flat
mount examination; Tarallo et al., 2012), we cannot exclude
the possibility that global microRNA perturbation due to DICER1
inhibition also contributes to or modulates iron-overload-
induced retinal toxicity.
These findings also provide support for pathogenic roles for
both inflammasome activation and iron overload in human
AMD. Inflammasome signaling in human AMD tissues has now
been observed bymultiple laboratories (Chan et al., 2013; Tarallo
et al., 2012; Tseng et al., 2013). Experimentally, multiple AMD-
related stimuli including Alu RNA (Kerur et al., 2013; Tseng
et al., 2013), A2E (Anderson et al., 2013), complement cascade
components (Doyle et al., 2012; Triantafilou et al., 2013), amy-
loid-b (Liu et al., 2013), and excess VEGF-A (Marneros, 2013)
have been reported to act via inflammasome signaling. Our re-
sults suggest that targeting inflammasome signaling compo-
nents as a ‘‘next-generation’’ therapeutic for AMD may provide
additional, unanticipated benefits with respect to phenotypes
arising from iron overload. Notably, our findings reveal that
Figure 3. Iron Overload Enhances Stability of Alu RNA
(A) Processing of a synthetic biotin-labeled Alu RNA transiently transfected in ARPE-19 exposed to 1 mM Fe(III). x axis denotes time following 2-hr RNA-loading
period.
(B) Quantity of endogenous AluRNA accumulated during a 4-hr modified nucleotide doping pulse (4 hr) or after washout (20 hr) in ARPE-19 cells exposed to 1mM
Fe(III). Alu RNAs were quantified by qPCR of size-separated RNA samples, in which RNAs 100–800 nt were isolated after PAGE.
(C) Northern blotting of Alu RNA of human ARPE-19 cells treated with control or DICER1-targeted antisense oligonucleotides and exposed to indicated doses of
Fe(III).
(D) Polyacrylamide gel separated Alu RNA after incubation with recombinant DICER1 in the presence of indicated quantities of Fe(III).
For all panels, n = 3–6; *p < 0.05. Error bars denote SEM.
1690 Cell Reports 11, 1686–1693, June 23, 2015 ª2015 The Authors
NLRP3 alone does not account for the entirety of iron-induced
RPE degeneration. Therefore, it will be important in future
studies to determine the extent to which NLRP3-independent in-
flammasome activation contributes to the AMD and pathological
effects of AMD-related inflammasome agonists. Further, our
studies utilized a mouse line lacking both caspase-1 and the
non-canonical inflammasome component caspase-11, which
were protected from treatment with a relatively high dose of
iron. Whether non-canonical inflammasome activation is
required for iron-induced toxicity is an important future direction
for study.
PCBP2 is an RNA-binding protein and iron chaperone, with
diverse cellular functions such as RNA stability (Czyzyk-Krzeska
and Bendixen, 1999; Paulding and Czyzyk-Krzeska, 1999; Xin
et al., 2011), protein stability (You et al., 2009), immunity (Blyn
et al., 1996, 1997; You et al., 2009), microRNA processing
(Li et al., 2012), iron homeostasis (Lane and Richardson, 2014),
preventing stress-induced apoptosis (Ghosh et al., 2008), cell
growth (Han et al., 2013; Waggoner et al., 2009), and tumor
growth (Han et al., 2013; Hu et al., 2014). The extent to which
these diverse functions of PCBP2, as well as its SINE RNA-pro-
cessing activity, contribute to inflammasome activation and iron-
induced RPE degeneration in geographic atrophy warrants
further investigation.
Iron overload has been observed in numerous neurodegener-
ative disorders including in senile plaques and neurofibrillary
tangles of human cadaver brains with Alzheimer’s disease (Quin-
tana et al., 2006; Sayre et al., 2000; Smith et al., 1997) and in the
substantia nigra of humans with Parkinson’s disease (Ayton and
Lei, 2014; Dexter et al., 1987). Interestingly, the involvement of
the NLRP3 inflammasome has been independently implicated
in the pathogenesis of these diseases (Codolo et al., 2013;
Freeman et al., 2013; Heneka et al., 2013). This study raises
the intriguing possibility that the damaging effects of Alu RNA
accretion due to iron overload could extend beyond AMD and
contribute to neurodegenerative diseases with recognized etio-
logical similarities. These findings also raise the interesting
possibility that systemic iron overload promotes NLRP3 inflam-
masome activation outside of the eye, such as in hepatic
macrophages, where inflammatory phenotypes such as NF-kB
activation and cytokine expression are noted effects of iron over-
load in liver injury (Lin et al., 1997; Xiong et al., 2008).
Figure 4. Iron Sensitivity of DICER1 Processing of Alu RNAs Is Mediated by PCBP2
(A) Western blotting of streptavidin-mediated pull-down and whole-cell lysates from biotin-Alu or biotin-tRNA-transfected human ARPE-19 cells that were
exposed to 1 mM Fe(III).
(B) Northern blotting of nativeAlu and 5S RNAs in human ARPE-19 exposed to 1mMFe(III) following immuno-precipitation with anti-PCBP2 antibody or in whole-
cell lysates.
(C) DICER1-mediated Alu RNA cleavage quantified from in vitro dicing reactions containing recombinant human DICER1, recombinant human PCBP2, and
100 mM Fe(III) where indicated. For all panels, n = 3–6; *p < 0.05. Error bars denote SEM.
(D) Proposedmodel of iron-overload-induced retinal toxicity, involving the sequestration of PCBP2 fromAluRNA/DICER1 complexes, leading to an accumulation
of Alu RNAs, NLRP3 inflammasome activation, and retinal degeneration.
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EXPERIMENTAL PROCEDURES
Intraocular Injections and Imaging
All animal experiments were in accordance with the guidelines of the University
of Kentucky Institutional Animal Care and Use Committee and the Association
for Research in Vision and Ophthalmology. Subretinal injections and intravitre-
ous injections (1 ml each) were performedwith a 35-gauge Exmiremicrosyringe
(Ito). Fundus imaging was performed on a TRC-50 IX camera (Topcon) linked
to a digital imaging system (Sony). RPE flat mounts were immunolabeled using
antibodies against Zonula Occludens-1 (Invitrogen) and visualized by confocal
microscopy (LeicaMicrosystems). Cryosections of 4%PFA fixed retinal cross-
sections were immuno-labeled with anti-Nlrp3 (Abcam) and visualized by fluo-
rescent microscopy (Nikon).
RNA and Protein Abundance Analysis
In situ hybridization was performed on frozen, fixed tissue sections from
Ceph//Heph/, and wild-type (C57BL/6J) age-matched mice were pro-
cessed using custom designed probes for B1 and B2 RNAs (Advanced Cell
Diagnostics) according to the manufacturer’s instructions. Probes were visu-
alized by confocal microscopy (Leica Microsystems). Quantities of B1,
B2 U6, and 5S RNAswere determined by northern blotting. Protein abundance
was measured by western blotting with the following primary antibodies:
mouse-anti-PCBP2 (Abnova; 1:500), rabbit-anti-DICER1 (Bethyl Laboratories;
1:1,000), mouse-anti-a-tubulin (Sigma; 1:1,000), rabbit-anti-caspase-1 (Invi-
trogen, 1:1,000 or Abcam, 1:1,000), mouse-anti-NLRP3 (Enzo Life Sciences;
1:1,000), anti-b-actin (Sigma-Aldrich; 1:1,000), and rabbit-anti-vinculin
(Sigma-Aldrich; 1:1,000).
Statistical Analysis
Results are expressed as mean ± SEM, with p values < 0.05 considered sta-
tistically significant. Differences between groups were compared by Mann-
Whitney U test or Student’s t test, as appropriate.
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